Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
Nihon Geka Gakkai Zasshi|June 1, 1986
[An in vitro sensitivity assay for anti-cancer agents by measuring the inhibition rate of DNA synthesis (3H-thymidine uptake of cancer cells). II. Clinical study of 110 cases of breast cancer]Y Nio, K Ohgaki, T Inamoto, et al.Anticancer Research|May 16, 2000
Anticancer chemosensitivity profiles of human breast cancer cells assessed by in vitro DNA synthesis inhibition assayY Nio, K Tamura, N Kan, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
In vivo and in vitro synergistic antitumor effect of interleukin-2-cultured tumor-bearer spleen cells and immune fresh spleen cellsN Kan, T Okino, M Nakanishi, et al.Nihon Geka Gakkai Zasshi|November 1, 1987
[Breast cancer-specific immunity evaluated by a new in vitro method--IL-2 enhanced MLTR]N Kan, T Okino, H Kodama, et al.Nihon Geka Gakkai Zasshi|August 1, 1984
[Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma]T Hori, N Kan, K Ohgaki, et al.Surgery Today|January 1, 1994
OK-432-combined adoptive immunotherapy as a prognostic factor in peritoneal metastasis from gastric cancerK Mise, N Kan, T Okino, et al.The British Journal of Surgery|July 1, 1991
Problems in the definition and treatment of early gastric cancerK Inoue, T Tobe, N Kan, et al.Cancer Research|February 1, 1978
Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapyI Jardine, C Fenselau, M Appler, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Immunotherapy of gastric cancer]N Kan, K Ohgaki, T Okino, et al.Nihon Geka Gakkai Zasshi|March 1, 1986
[Augmentation of the anti-tumor activity of regional lymph node lymphocytes and spleen cells of tumor-bearing mice by culture with T cell growth factor in vitro--a comparison of the intestinal cancer model and footpad cancer model]T Hori, N Kan, T Inamoto, et al.Pageof 8